Effects of Hawthorn Fruit Extract Administration on Asprosin, Thyroid Hormones, and Nutritional Performance in Diabetic Rats

Ümmü Gülşen Bozok; Gülbahar Böyük Özcan; Bülent Bayraktar; Gökşad Cemil Kotan

doi:10.24925/turjaf.v14i9.2549-2555.9088

Authors

Ümmü Gülşen Bozok Ankara Medipol University, Faculty of Medicine, Department of Physiology, Ankara, Türkiye https://orcid.org/0000-0002-2016-7305
Gülbahar Böyük Özcan Ankara Medipol University, Faculty of Medicine, Department of Physiology, Ankara, Türkiye https://orcid.org/0000-0002-3453-2967
Bülent Bayraktar Bayburt University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Bayburt, Türkiye https://orcid.org/0000-0002-2335-9089
Gökşad Cemil Kotan Hitit University, Alaca Avni Çelik Vocational School, Department of Veterinary Medicine, Çorum, Türkiye https://orcid.org/0000-0001-7064-917X

DOI:

https://doi.org/10.24925/turjaf.v14i9.2549-2555.9088

Keywords:

Asprosin, Diabetic rats, Feeding behavior, Hawthorn fruit extract, Thyroid hormones

Abstract

This study aimed to determine the effects of hawthorn fruit extract (HFE) administration on asprosin and thyroid hormone (T3, T4, and TSH) responses, as well as on feeding behavior and feed efficiency performance in experimentally induced Type 1 diabetic rats. Sixty-four male Wistar Albino rats used in the study were allocated into eight different groups, each comprising eight animals. Following group allocation, diabetes induction was performed in the diabetic groups via a single dose of 50 mg/kg Streptozotocin (STZ), and metabolic processes were monitored by incorporating varying levels of HFE (100, 200, and 300 mg/kg) into their diets for 21 days.

The study results revealed that serum asprosin levels in the diabetic control (DC) group reached 2.45 ± 0.12 ng/ml, exhibiting an approximate two-fold increase compared to the healthy control group (1.20 ± 0.04 ng/ml) (p < 0.01). Conversely, the administration of 200 mg/kg HFE significantly improved this parameter by reducing the level to 1.65 ± 0.08 ng/ml. Regarding endocrine findings, TSH (0.17 ± 0.01 uIU/mL), T3 (1.60 ± 0.04 pg/mL), and T4 (0.92 ± 0.04 ng/dL) levels in the DC group dropped substantially compared to the control group; however, the TSH value in the DH200 group reached 0.23 ± 0.01 uIU/mL, normalizing back to healthy control values.

In terms of zootechnical parameters, the highest daily feed intake (36.4 ± 2.8 g) and water consumption (125.6 ± 10.4 ml) were recorded in the DC group, accompanied by a severe body weight loss of -38.2 ± 6.2 g and a consequently negative feed conversion ratio (FCR) of -0.12 ± 0.01. Consequently, restricting the body weight loss to -12.4 ± 3.5 g and elevating the FCR value to 0.18 ± 0.03 in the DH200 group scientifically demonstrates that HFE is a safe and effective natural strategy that ameliorates biochemical damage in diabetic metabolism while supporting the general performance characteristics and nutritional parameters of the animals.

In conclusion, it has been proven that HFE is a safe and effective natural strategy that restores the asprosin hormone response in diabetic metabolism while simultaneously supporting the general performance traits and nutritional parameters of the animals. For the zootechnical management of diabetic complications, suppression of asprosin-induced appetite dysregulation, and regulation of hormone levels by preserving the thyroid response, the HFE application at a dose of 200 mg/kg is recommended as both the safest and most effective dose.

References

Bayar, S., Erdoğan, M., Taşdemir, A., Kaleli, A. R., & Paloluoğlu, C. (2025). Artificial neural network modelling of reactive red 45 azo dye removal by peroxi-electrocoagulation. International Journal of Environmental Science and Technology, 22, 16779–16794. https://doi.org/10.1007/s13762-025-06738-1

Biondi, B., Kahaly, G. J., & Robertson, R. P. (2019). Thyroid dysfunction and diabetes mellitus: Two closely associated disorders. Endocrine Reviews, 40(3), 789–824. https://doi.org/10.1210/er.2018-00163

Chauhan, A., & Patel, S. S. (2024). Thyroid hormone and diabetes mellitus interplay: Making management of comorbid disorders complicated. Hormone and Metabolic Research, 56(12), 845–858. https://doi.org/ 10.1055/a-2374-8756

Chen, Y., Zhou, Z., Li, X. X., & Wang, T. (2017). Research on the protective effects of antioxidants on metabolic syndrome induced by thyroid dysfunction. European Review for Medical and Pharmacological Sciences, 21(10), 2489–2498.

Derkach, K. V., Moiseyuk, I. V., Shpakova, E. A., & Shpakov, A. O. (2015). The thyroid status of rats immunized with peptides derived from the extracellular regions of the types 3 and 4 melanocortin receptors and the 1B-subtype 5-hydroxytryptamine receptor. Journal of Evolutionary Biochemistry and Physiology, 51(4), 279–287. https://doi.org/10.1134/S0022093015040031

Didushko, O. M., Kostitska, I. O., Cherniavska, I. V., Artemenko, N. R., & Romaniv, T. V. (2025). Herbal and mineral composition for the management of thyroid dysfunction. International Journal of Endocrinology (Ukraine), 21(3), 273–277. https://doi.org/10.22141/2224-0721.21.3.2025.1538

Dilworth, L., Facey, A., & Omoruyi, F. (2021). Diabetes mellitus and its metabolic complications: The role of adipose tissues. International Journal of Molecular Sciences, 22(14), 7644. https://doi.org/10.3390/ijms22147644

Dinda, B., & Dinda, M. (2022). Natural products, a potential source of new drugs discovery to combat obesity and diabetes: Their efficacy and multi-targets actions in treatment of these diseases. In Natural products in obesity and diabetes: Therapeutic potential and role in prevention and treatment (pp. 101–275). Springer International Publishing. https://doi.org/10.1007/978-3-030-92196-5_4

Duerrschmid, C., He, Y., Wang, C., Li, C., Bournat, J. C., Romere, C., ... & Chopra, A. R. (2017). Asprosin is a centrally acting orexigenic hormone. Nature Medicine, 23(12), 1444–1453. https://doi.org/10.1038/nm.4432

Farrag, M., Ait Eldjoudi, D., González-Rodríguez, M., Cordero-Barreal, A., Ruiz-Fernandez, C., Capuozzo, M., ... & Gualillo, O. (2023). Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects. Frontiers in Endocrinology, 13, 1101091. https://doi.org/10.3389/fendo.2022.1101091

Goldberg, D., & Goldstein, I. (2026). Endocrine regulation of the hepatic fasting response: Cues, cooperation and consequences. Nature Reviews Endocrinology, 1–15. https://doi.org/10.1038/s41574-025-01228-3

Hassan, H. J., Hameed, E. K., & Mohammad, T. U. (2024). Asprosin: The potential player in combined double diabetes and hypothyroidism. Irish Journal of Medical Science (1971-), 193(6), 2915–2921. https://doi.org/10.1007/s11845-024-03758-7

Hoffmann, J. G., Xie, W., & Chopra, A. R. (2020). Energy regulation mechanism and therapeutic potential of asprosin. Diabetes, 69(4), 559–566. https://doi.org/10.2337/dbi19-0009

Jurikova, T., Sochor, J., Rop, O., Mlcek, J., Balla, S., Szekeres, L., ... & Kizek, R. (2012). Polyphenolic profile and biological activity of Chinese Hawthorn (Crataegus pinnatifida BUNGE) fruits. Molecules, 17(12), 14490–14509. https://doi.org/10.3390/molecules171214490

Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., ... & Lernmark, Å. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3, 17016. https://doi.org/10.1038/nrdp.2017.16

Kępińska-Pacelik, J., & Biel, W. (2026). Hawthorn (Crataegus monogyna Jacq.): A review of therapeutic potential and applications. Molecules, 31(2), 226. https://doi.org/10.3390/molecules31020226

Li, Y. Z., Zhang, Y. T., & Li, X. H. (2026). Functions of exosomal microRNAs from adipose tissue in diabetes mellitus and related cardiovascular pathologies. Cell Cycle, 25(1), 1–19. https://doi.org/10.1080/15384101.2025.2590058

Mazur-Bialy, A. I. (2021). Asprosin—A fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients, 13(2), 620. https://doi.org/10.3390/nu13020620

Mittal, R., Weiss, M. B., Rendon, A., Shafazand, S., Lemos, J. R., & Hirani, K. (2025). Harnessing machine learning, a subset of artificial intelligence, for early detection and diagnosis of type 1 diabetes: A systematic review. International Journal of Molecular Sciences, 26(9), 3935. https://doi.org/10.3390/ijms26093935

Mohammed, H. Y., Ebeed, N. M., & Al-Senosy, N. K. (2026). Therapeutic efficacy of Thymus vulgaris in restoring pancreatic β-cell function in Type 1 diabetes rats. Egyptian Journal of Veterinary Sciences, 57(1), 1–14. https://doi.org/10.21608/ejvs.2026.459118.3442

Mousa, A. M., & Allemailem, K. S. (2025). Could hawthorn have a cardioprotective impact against obesity-induced cardiac injury in rats via antioxidant, hypolipidemic, anti-inflammatory, antiapoptotic, and antifibrotic properties?. Tissue and Cell, 93, 102673. https://doi.org/ 10.1016/j.tice.2024.102673

Nazhand, A., Lucarini, M., Durazzo, A., Zaccardelli, M., Cristarella, S., Souto, S. B., ... & Santini, A. (2020). Hawthorn (Crataegus spp.): An updated overview on its beneficial properties. Forests, 11(5), 564. https://doi.org/10.3390/f11050564

Orkun Erkılıç, T., & Bayraktar, B. (2025a). Effect of Moringa oleifera oil extract on adipokine (Apelin, Visfatin and Nesfatin-1) and cardiac (cTnI) response in streptozotocin-induced rats. Indian Journal of Animal Research, 59(1), 104–109. https://doi.org/10.1055/IJAR.BF-1904

Orkun Erkılıç, T., & Bayraktar, B. (2025b). Effect of jackfruit pulp extract on serum Nesfatin-1 and Visfatin levels in streptozotocin-induced rats. Indian Journal of Animal Research, 59(2), 215–221. https://doi.org/ 10.18805/IJAR.BF-1902.

Paloluoğlu, C. (2024). Correlating gas/particle-phase concentration of indicator polychlorinated biphenyls with meteorological factors in Bayburt, an important university city of Turkey. Journal of Anatolian Environmental and Animal Sciences, 9(2), 205–220. https://doi.org/10.35229/jaes.1425886

Paloluoğlu, C., & Bayraktar, H. (2022). Determination of the gas/particle phase concentrations of PCBs in urban and rural atmosphere in Erzurum, Turkey. Environmental Monitoring and Assessment, 194(10). https://doi.org/10.1007/s10661-022-10443-8

Rafeeq, J., Qaisar, K. N., Khan, P. A., Mugloo, J. A., Singh, A., Hassan, I., ... & Sultan, A. (2023). Regulation of phytochemical properties of hawthorn: A Crataegus species. In Genetic Manipulation of Secondary Metabolites in Medicinal Plants (pp. 179–203). Springer Nature Singapore. https://doi.org/10.1007/978-981-99-4939-7_8

Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., ... & Gao, D. (2022). Adipokines, hepatokines and myokines: Focus on their role and molecular mechanisms in adipose tissue inflammation. Frontiers in Endocrinology, 13, 873699. https://doi.org/10.3389/fendo.2022.873699

Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., ... & Chopra, A. R. (2016). Asprosin, a fasting-induced glucogenic protein hormone. Cell, 165(3), 566–579. https://doi.org/10.1016/j.cell.2016.02.063

Teixeira, P. d. F. d. S., Dos Santos, P. B., & Pazos-Moura, C. C. (2020). The role of thyroid hormone in metabolism and metabolic syndrome. Therapeutic Advances in Endocrinology and Metabolism, 11, 2042018820917869. https://doi.org/10.1177/204201882091786

Wang, C., Dai, X., Zhang, D., Liu, Z., & Huang, Q. (2018). Jinlida granules improve dysfunction of hypothalamic-pituitary-thyroid axis in diabetic rats induced by STZ. BioMed Research International, 2018, 4764030. https://doi.org/10.1155/2018/4764030

Wu, M., Liu, L., Xing, Y., Yang, S., Li, H., & Cao, Y. (2020). Roles and mechanisms of hawthorn and its extracts on atherosclerosis: A review. Frontiers in Pharmacology, 11, 118. https://doi.org/10.3389/fphar.2020.00118

Xu, H., Zhao, X., Bai, H., & Li, S. (2026). Regulatory effects of hawthorn on lipid metabolic homeostasis: Mechanisms, evidences, and perspectives. Frontiers in Nutrition, 13, 1807050. https://doi.org/10.3389/fnut.2026.1807050

Yılmaz, A. E., Boncukcuoğlu, R., Kocakerim, M. M., Yılmaz, M. T., & Paloluoğlu, C. (2008). Boron removal from geothermal waters by electrocoagulation. Journal of Hazardous Materials. https://doi.org/10.1016/j.jhazmat.2007.08.030

Yuan, M., Li, W., Zhu, Y., Yu, B., & Wu, J. (2020). Asprosin: A novel player in metabolic diseases. Frontiers in Endocrinology, 11, 64. https://doi.org/10.3389/fendo.2020.00064